These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 18780866)

  • 1. Re: Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy?
    Bhutani M; Pathak AK
    J Natl Cancer Inst; 2008 Sep; 100(18):1334; author reply 1334-5. PubMed ID: 18780866
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy?
    Simone CB; Simone CB
    J Natl Cancer Inst; 2008 Nov; 100(21):1558-9; author reply 1559-1560. PubMed ID: 18957669
    [No Abstract]   [Full Text] [Related]  

  • 3. Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy?
    Lawenda BD; Kelly KM; Ladas EJ; Sagar SM; Vickers A; Blumberg JB
    J Natl Cancer Inst; 2008 Jun; 100(11):773-83. PubMed ID: 18505970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re: Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy?
    Block K; Koch A; Mead M; Newman RA; Gyllenhaal C
    J Natl Cancer Inst; 2009 Jan; 101(2):124-5; author reply 125-6. PubMed ID: 19141775
    [No Abstract]   [Full Text] [Related]  

  • 5. Multiple dietary antioxidants enhance the efficacy of standard and experimental cancer therapies and decrease their toxicity.
    Prasad KN
    Integr Cancer Ther; 2004 Dec; 3(4):310-22. PubMed ID: 15523102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antioxidant conundrum in cancer.
    Seifried HE; McDonald SS; Anderson DE; Greenwald P; Milner JA
    Cancer Res; 2003 Aug; 63(15):4295-8. PubMed ID: 12907593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary antioxidants and human cancer.
    Borek C
    Integr Cancer Ther; 2004 Dec; 3(4):333-41. PubMed ID: 15523104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diseases desperate grown.
    Bunn PA
    J Natl Cancer Inst; 2008 Apr; 100(8):520-1. PubMed ID: 18398099
    [No Abstract]   [Full Text] [Related]  

  • 9. Definite, probable or dubious: antioxidants trilogy in clinical dentistry.
    Carnelio S; Khan SA; Rodrigues G
    Br Dent J; 2008 Jan; 204(1):29-32. PubMed ID: 18192996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral antioxidants and cardiovascular health in the exercise-trained and untrained elderly: a radically different outcome.
    Wray DW; Uberoi A; Lawrenson L; Bailey DM; Richardson RS
    Clin Sci (Lond); 2009 Mar; 116(5):433-41. PubMed ID: 18795893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspects of antioxidant foods and supplements in health and disease.
    Herrera E; Jiménez R; Aruoma OI; Hercberg S; Sánchez-García I; Fraga C
    Nutr Rev; 2009 May; 67 Suppl 1():S140-4. PubMed ID: 19453669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surviving antioxidant supplements.
    Bjelakovic G; Gluud C
    J Natl Cancer Inst; 2007 May; 99(10):742-3. PubMed ID: 17505064
    [No Abstract]   [Full Text] [Related]  

  • 13. Antioxidants and cancer therapy: furthering the debate.
    Block KI
    Integr Cancer Ther; 2004 Dec; 3(4):342-8. PubMed ID: 15523105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antioxidant supplements: bad news and good news.
    Harv Mens Health Watch; 2003 Feb; 7(7):1-5. PubMed ID: 12604442
    [No Abstract]   [Full Text] [Related]  

  • 15. Antioxidant supplementation and risk of skin cancers.
    Ezzedine K; Hercberg S; Malvy D
    Arch Dermatol; 2010 May; 146(5):567-8; author reply 568. PubMed ID: 20479316
    [No Abstract]   [Full Text] [Related]  

  • 16. Re-evaluating duration of therapy in advanced non-small-cell lung cancer: is it really duration or is it more about timing and exposure?
    Socinski MA
    J Clin Oncol; 2009 Jul; 27(20):3268-70. PubMed ID: 19470913
    [No Abstract]   [Full Text] [Related]  

  • 17. Re: 'A threefold dose intensity treatment with ifosfamide, carboplatin, and etoposide for patients with small-cell lung cancer: a randomized trial'.
    Bregni M; Pedrazzoli P
    J Natl Cancer Inst; 2009 Jan; 101(1):67; author reply 67-8. PubMed ID: 19116385
    [No Abstract]   [Full Text] [Related]  

  • 18. Rationale for using high-dose multiple dietary antioxidants as an adjunct to radiation therapy and chemotherapy.
    Prasad KN
    J Nutr; 2004 Nov; 134(11):3182S-3S. PubMed ID: 15514298
    [No Abstract]   [Full Text] [Related]  

  • 19. Administration of antioxidants in cancer: debate of the decade.
    Khurana RK; Jain A; Jain A; Sharma T; Singh B; Kesharwani P
    Drug Discov Today; 2018 Apr; 23(4):763-770. PubMed ID: 29317341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International Clinical Trials in Radiation Oncology. Chemical modifiers.
    Bartelink H; Bleehen NM; Phillips TL
    Int J Radiat Oncol Biol Phys; 1988; 14 Suppl 1():S39-49. PubMed ID: 3292481
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.